DRI Healthcare Trust (TSE:DHT.UN – Get Free Report) had its target price lifted by research analysts at Raymond James Financial from C$22.50 to C$23.50 in a research report issued on Monday,BayStreet.CA reports. The firm currently has a “strong-buy” rating on the stock. Raymond James Financial’s price objective points to a potential upside of 27.72% from the company’s previous close.
A number of other equities research analysts also recently weighed in on the company. National Bank Financial boosted their price target on DRI Healthcare Trust from C$22.50 to C$23.50 and gave the company an “outperform” rating in a report on Tuesday, May 19th. Stifel Nicolaus lifted their price target on shares of DRI Healthcare Trust from C$22.00 to C$23.00 and gave the company a “buy” rating in a report on Tuesday, May 19th. Finally, Scotiabank raised their target price on shares of DRI Healthcare Trust from C$25.00 to C$30.00 and gave the stock a “sector outperform” rating in a report on Tuesday, May 19th. One investment analyst has rated the stock with a Strong Buy rating and three have issued a Buy rating to the company’s stock. Based on data from MarketBeat, DRI Healthcare Trust has an average rating of “Buy” and a consensus price target of C$25.00.
View Our Latest Stock Analysis on DHT.UN
DRI Healthcare Trust Stock Performance
DRI Healthcare Trust Company Profile
DRI Healthcare Trust is managed by DRI Capital Inc DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S.
Recommended Stories
- Five stocks we like better than DRI Healthcare Trust
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.
